Epilepsy Market Report

Global and Region Epilepsy Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：191
  • REPORT CODE：GMM888933
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Epilepsy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Epilepsymarket, defines the market attractiveness level of Epilepsy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Epilepsy industry, describes the types of Epilepsy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Epilepsy market and the development prospects and opportunities of Epilepsy industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Epilepsy market in Chapter 13.

    By Player:

    • Abbott Laboratories

    • Medtronic PLC (Ireland)

    • GlaxoSmithKline PLC

    • Sanofi

    • UCB SA

    • Johnson & Johnson Services

    • Bausch Health

    • Sunovion Pharmaceuticals

    • Pfizer

    • Novartis AG

    • Takeda

    • Eisai

    • NeuroPace

    • LivaNova

    • GW Pharmaceuticals

    By Type:

    • Partial/focal Seizure

    • Generalized Seizure

    • Myoclonus Misses

    • Negative Myoclonus

    • Eyelid Myoclonus

    • Laughter

    • Others

    By End-User:

    • Hospitals

    • Neurology Centers

    • Home Care Settings

    • Ambulatory Surgical Centers

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Epilepsy Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Epilepsy Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Epilepsy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Epilepsy Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Epilepsy Market Analysis and Outlook to 2022

    • 7.1 Global Epilepsy Consumption (2017-2022)

    • 7.2 United States Epilepsy Consumption (2017-2022)

    • 7.3 Europe Epilepsy Consumption (2017-2022)

    • 7.4 China Epilepsy Consumption (2017-2022)

    • 7.5 Japan Epilepsy Consumption (2017-2022)

    • 7.6 India Epilepsy Consumption (2017-2022)

    • 7.7 South Korea Epilepsy Consumption (2017-2022)

    8 Region and Country-wise Epilepsy Market Analysis and Outlook to 2028

    • 8.1 Global Epilepsy Consumption Forecast (2022-2028)

    • 8.2 United States Epilepsy Consumption Forecast (2022-2028)

    • 8.3 Europe Epilepsy Consumption Forecast (2022-2028)

    • 8.4 China Epilepsy Consumption Forecast (2022-2028)

    • 8.5 Japan Epilepsy Consumption Forecast (2022-2028)

    • 8.6 India Epilepsy Consumption Forecast (2022-2028)

    • 8.7 South Korea Epilepsy Consumption Forecast (2022-2028)

    9 Global Epilepsy Market Outlook by Types and Applications to 2022

    • 9.1 Global Epilepsy Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Partial/focal Seizure Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Generalized Seizure Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Myoclonus Misses Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Negative Myoclonus Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Eyelid Myoclonus Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Laughter Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Epilepsy Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Neurology Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Home Care Settings Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Epilepsy Market Outlook by Types and Applications to 2028

    • 10.1 Global Epilepsy Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Partial/focal Seizure Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Generalized Seizure Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Myoclonus Misses Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Negative Myoclonus Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Eyelid Myoclonus Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Laughter Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Epilepsy Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Neurology Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Home Care Settings Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Epilepsy Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Epilepsy Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Epilepsy Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Epilepsy Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Epilepsy Market Competitive Analysis

    • 14.1 Abbott Laboratories

      • 14.1.1 Abbott Laboratories Company Details

      • 14.1.2 Abbott Laboratories Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Abbott Laboratories Epilepsy Product and Service

    • 14.2 Medtronic PLC (Ireland)

      • 14.2.1 Medtronic PLC (Ireland) Company Details

      • 14.2.2 Medtronic PLC (Ireland) Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Medtronic PLC (Ireland) Epilepsy Product and Service

    • 14.3 GlaxoSmithKline PLC

      • 14.3.1 GlaxoSmithKline PLC Company Details

      • 14.3.2 GlaxoSmithKline PLC Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 GlaxoSmithKline PLC Epilepsy Product and Service

    • 14.4 Sanofi

      • 14.4.1 Sanofi Company Details

      • 14.4.2 Sanofi Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sanofi Epilepsy Product and Service

    • 14.5 UCB SA

      • 14.5.1 UCB SA Company Details

      • 14.5.2 UCB SA Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 UCB SA Epilepsy Product and Service

    • 14.6 Johnson & Johnson Services

      • 14.6.1 Johnson & Johnson Services Company Details

      • 14.6.2 Johnson & Johnson Services Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Johnson & Johnson Services Epilepsy Product and Service

    • 14.7 Bausch Health

      • 14.7.1 Bausch Health Company Details

      • 14.7.2 Bausch Health Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bausch Health Epilepsy Product and Service

    • 14.8 Sunovion Pharmaceuticals

      • 14.8.1 Sunovion Pharmaceuticals Company Details

      • 14.8.2 Sunovion Pharmaceuticals Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Sunovion Pharmaceuticals Epilepsy Product and Service

    • 14.9 Pfizer

      • 14.9.1 Pfizer Company Details

      • 14.9.2 Pfizer Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Pfizer Epilepsy Product and Service

    • 14.10 Novartis AG

      • 14.10.1 Novartis AG Company Details

      • 14.10.2 Novartis AG Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Novartis AG Epilepsy Product and Service

    • 14.11 Takeda

      • 14.11.1 Takeda Company Details

      • 14.11.2 Takeda Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Takeda Epilepsy Product and Service

    • 14.12 Eisai

      • 14.12.1 Eisai Company Details

      • 14.12.2 Eisai Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Eisai Epilepsy Product and Service

    • 14.13 NeuroPace

      • 14.13.1 NeuroPace Company Details

      • 14.13.2 NeuroPace Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 NeuroPace Epilepsy Product and Service

    • 14.14 LivaNova

      • 14.14.1 LivaNova Company Details

      • 14.14.2 LivaNova Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 LivaNova Epilepsy Product and Service

    • 14.15 GW Pharmaceuticals

      • 14.15.1 GW Pharmaceuticals Company Details

      • 14.15.2 GW Pharmaceuticals Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 GW Pharmaceuticals Epilepsy Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Epilepsy

    • Figure Epilepsy Picture

    • Table Global Epilepsy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Epilepsy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Epilepsy Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Epilepsy Consumption by Country (2017-2022)

    • Figure United States Epilepsy Consumption and Growth Rate (2017-2022)

    • Table Europe Epilepsy Consumption and Growth Rate (2017-2022)

    • Figure China Epilepsy Consumption and Growth Rate (2017-2022)

    • Figure Japan Epilepsy Consumption and Growth Rate (2017-2022)

    • Figure India Epilepsy Consumption and Growth Rate (2017-2022)

    • Figure South Korea Epilepsy Consumption and Growth Rate (2017-2022)

    • Figure Global Epilepsy Consumption Forecast by Country (2022-2028)

    • Figure United States Epilepsy Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Epilepsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Epilepsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Epilepsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Epilepsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Epilepsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Partial/focal Seizure Consumption and Growth Rate (2017-2022)

    • Figure Global Generalized Seizure Consumption and Growth Rate (2017-2022)

    • Figure Global Myoclonus Misses Consumption and Growth Rate (2017-2022)

    • Figure Global Negative Myoclonus Consumption and Growth Rate (2017-2022)

    • Figure Global Eyelid Myoclonus Consumption and Growth Rate (2017-2022)

    • Figure Global Laughter Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Neurology Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Home Care Settings Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Partial/focal Seizure Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Generalized Seizure Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Myoclonus Misses Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Negative Myoclonus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Eyelid Myoclonus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Laughter Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurology Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Home Care Settings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Epilepsy Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Epilepsy Export by Region (Top 5 Countries) (2017-2028)

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Epilepsy Product and Service

    • Table Medtronic PLC (Ireland) (Foundation Year, Company Profile and etc.)

    • Table Medtronic PLC (Ireland) Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic PLC (Ireland) Epilepsy Product and Service

    • Table GlaxoSmithKline PLC (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline PLC Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline PLC Epilepsy Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Epilepsy Product and Service

    • Table UCB SA (Foundation Year, Company Profile and etc.)

    • Table UCB SA Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table UCB SA Epilepsy Product and Service

    • Table Johnson & Johnson Services (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Services Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Services Epilepsy Product and Service

    • Table Bausch Health (Foundation Year, Company Profile and etc.)

    • Table Bausch Health Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bausch Health Epilepsy Product and Service

    • Table Sunovion Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Sunovion Pharmaceuticals Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sunovion Pharmaceuticals Epilepsy Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Epilepsy Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Epilepsy Product and Service

    • Table Takeda (Foundation Year, Company Profile and etc.)

    • Table Takeda Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Epilepsy Product and Service

    • Table Eisai (Foundation Year, Company Profile and etc.)

    • Table Eisai Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Epilepsy Product and Service

    • Table NeuroPace (Foundation Year, Company Profile and etc.)

    • Table NeuroPace Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table NeuroPace Epilepsy Product and Service

    • Table LivaNova (Foundation Year, Company Profile and etc.)

    • Table LivaNova Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table LivaNova Epilepsy Product and Service

    • Table GW Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table GW Pharmaceuticals Epilepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table GW Pharmaceuticals Epilepsy Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US